Natera (NTRA)
(Delayed Data from NSDQ)
$124.16 USD
+3.20 (2.65%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $124.12 -0.04 (-0.03%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth F Momentum C VGM
Price, Consensus and EPS Surprise
NTRA 124.16 +3.20(2.65%)
Will NTRA be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for NTRA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NTRA
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy
NTRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Momentum Stocks to Buy for October 23rd
Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
Other News for NTRA
Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
Natera Inc (NTRA) Shares Down 3.16% on Oct 31
Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Natera price target raised to $135 from $125 at Bernstein